XOMA Corporation is a biotechnology royalty aggregator that helps enhance human health by acquiring the potential future economics of pre-commercial therapeutic candidates licensed to other companies. They focus on early to mid-stage clinical assets with commercial sales potential primarily in Phase 1 and 2 that are licensed to partners. XOMA has approximately 70 assets in its portfolio and is headquartered in Emeryville, California.